FDA clampdown driving Indian compliance investment; ICRA
Indian drugmakers will increase investment in GMP compliance to avoid becoming the next company hit by the FDA, a credit rating agency said.
Archives for March 20, 2012
Infosys sees growing Pharma demand for digital marketing and comms
Under pressure Pharmas are turning to digital channels to communicate with physicians and patients says Indian tech firm Infosys.
'Generic API manufacturers: look at drugs from launch', urges a new report
Generic API (active pharmaceutical ingredient) makers should consider the off-patent potential of a drug as soon as it is launched, according to a new study by PharmaIntellect.
Sigma Aldrich shortens China supply chains with Wuxi plant
Sigma Aldrich says new packaging facility in China will shorten supply chains and help it build in an increasingly important regional market.
Virtual dev needs blockbusters to sway herd, proponent says
The virtual development model needs a string of successes or blockbusters to convince the ‘herd’ of its merits, an expert said.
FDA to publish final rule on cGMP labelling controls today
The US FDA will today publish a final rule to change cGMP labelling controls, 15 years after proposing the revision.
inVentiv to buy Kforce Clinical Research for FSP biz boost
inVentiv Health will stump up $50m for contract staffing firm Kforce Clinical Research (KCR) to ramp up its funcatiuonal service provider (FSP) business.